These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21330931)

  • 41. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S; Biondi-Zoccai G; Silvestri P; Di Russo C; Musto C; Ferraiuolo G; Loschiavo P
    J Interv Cardiol; 2008 Feb; 21(1):1-7. PubMed ID: 18086133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronary stenting with the sirolimus-eluting stent in clinical practice: final results from the prospective multicenter German Cypher Stent Registry.
    Zahn R; Hamm CW; Schneider S; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Nienaber CA;
    J Interv Cardiol; 2010 Feb; 23(1):18-25. PubMed ID: 20002292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry.
    Park DW; Kim YH; Song HG; Ahn JM; Oh J; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Jung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    J Am Coll Cardiol; 2011 Jan; 57(2):128-37. PubMed ID: 21211683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of bare metal stent in drug eluting stent era].
    Takizawa K; Inoue N
    Nihon Rinsho; 2011 Feb; 69(2):265-70. PubMed ID: 21387674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures.
    Sharp AS; Latib A; Ielasi A; Larosa C; Godino C; Saolini M; Magni V; Gerber RT; Montorfano M; Carlino M; Michev I; Chieffo A; Colombo A
    Circ Cardiovasc Interv; 2009 Oct; 2(5):416-22. PubMed ID: 20031751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
    Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
    Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.
    Park DW; Kim YH; Yun SC; Song HG; Ahn JM; Oh JH; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    J Am Coll Cardiol; 2011 May; 57(21):2152-9. PubMed ID: 21596230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease.
    Lee MS; Yang T; Dhoot J; Iqbal Z; Liao H
    Am J Cardiol; 2010 Jun; 105(11):1540-4. PubMed ID: 20494658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Revascularization strategies in patients with Type 2 diabetes mellitus.
    Choi SS; Mehran R
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1337-47. PubMed ID: 24138521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No significant interaction between diabetes and clinical presentation in the outcome of percutaneous coronary intervention: have we considered silent ischemia?
    Agushi E
    J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):695. PubMed ID: 21792026
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of diabetes mellitus on angiographic and clinical outcomes after early generation drug-eluting stent implantation.
    Kim YH; Park SW
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1209-11. PubMed ID: 23190059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Myeloid metaplasia with myelofibrosis associated with acute coronary syndrome. Case report].
    Macovei L; Sârbu A; Enea D; Georgescu CA
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):397-400. PubMed ID: 21870730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Percutaneous coronary intervention for two acute myocardial infarction patients with isolated single coronary artery anomaly].
    Luo W; Chen BX; Ma FY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):369-70. PubMed ID: 17711672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.